Market Tide Weekly Structural financial analysis for readers who want clarity, not noise.

Long‑form investigations into the forces shaping today’s markets.


Sunset over the ocean with a cargo ship, city skyline with tall buildings, and stock market chart with candlestick patterns overlay. Text reads "Market Tide Weekly."

Start Here

Market Tide Weekly publishes structural financial analysis every Tuesday, with deep‑dive investigations every Thursday.

New to Market Tide? Start with this week’s Tuesday Edition, then explore the latest Deep Dive.


Ericsson's Second Act
Market Tide Weekly Deep Dive Market Tide Weekly Market Tide Weekly Deep Dive Market Tide Weekly

Ericsson's Second Act

Ericsson has spent years defending its position as one of the world's critical telecom infrastructure providers. Today, the company faces a larger challenge: proving that networks can become programmable platforms for software, APIs, AI-driven automation, and enterprise connectivity. While margin resilience, capital returns, and balance-sheet strength support the current investment case, the next phase of value creation may depend on Aduna, Network APIs, and Vonage evolving from strategic initiatives into economically meaningful businesses.

Read More
ZCMD’s Reverse-Current Problem
Market Tide Weekly Deep Dive Market Tide Weekly Market Tide Weekly Deep Dive Market Tide Weekly

ZCMD’s Reverse-Current Problem

The Lighthouse was built to catch what the price chart misses. This week, it caught ZCMD — not because the filings showed a clean turnaround, but because they revealed a pattern: weak operating disclosures, reverse-split authority, public offering mechanics, warrant-linked financing, ownership churn, and a second reverse split.

ZCMD is a reminder that structural pressure can hide behind headline price movement. A post-split chart can look cleaner while the filing trail tells a more complicated story. That is why we read the filings in sequence — and why the tide has nowhere to hide.

Read More
Market Tide Weekly — Lighthouse Report
Market Tide Weekly Market Tide Weekly

Market Tide Weekly — Lighthouse Report

The Lighthouse went live at 11:00 AM CT on July 1, 2026 — and its first sweep across the small‑cap ocean revealed a market already in motion. Continuity wasn’t scattered; it was clustered. Rising drift dominated nearly every sector, with Healthcare, Financials, Technology, and Industrials forming the strongest multi‑session attention bands. Persistent names held their ground, weakened names slipped into the periphery, and a small group of new entrants began their first measurable climb.

This report captures the structural signals detected during the Lighthouse’s opening scan: where attention is forming, where it’s fading, and where the next narrative is likely to emerge. Market Tide Weekly now tracks the tape from a higher vantage point — not reacting to volatility, but observing continuity as it builds.

Read More
Three Filing Stories the Market Misread This Week - SSTK, CRSR, CLYM
Market Tide Weekly - Tuesday Edition Market Tide Weekly Market Tide Weekly - Tuesday Edition Market Tide Weekly

Three Filing Stories the Market Misread This Week - SSTK, CRSR, CLYM

This week’s Market Tide Weekly highlights three companies where the filings tell a stronger story than the market’s first reaction. SSTK, CRSR, and CLYM each show structural signals—across operating quality, balance-sheet posture, and catalyst visibility—that suggest the narrative may be lagging the evidence.

Read More
BBOT Deep Dive: Resale Overhang, Governance Concentration, and H2 2026 Risk Map
Market Tide Weekly Market Tide Weekly

BBOT Deep Dive: Resale Overhang, Governance Concentration, and H2 2026 Risk Map

BridgeBio Oncology Therapeutics carries one of the most structurally consequential setups in the 2026 small‑cap biotech landscape: a 78.8% resale overhang, a leadership transition compressed into the days before a key EFFECT notice, and a governance map anchored by two dominant shareholder blocs. The clinical story is promising, but the filing record tells a second story — one about alignment, timing, and who is positioned to shape outcomes as BBOT enters its H2 2026 catalyst window.

Read More
CXDO Deep Dive: Crexendo Acquisition Filing Structure & Key Metrics (2024–2026)
Market Tide Weekly Market Tide Weekly

CXDO Deep Dive: Crexendo Acquisition Filing Structure & Key Metrics (2024–2026)

In this sample of the Market Tide Abyssal Deep Dive, we dive into Crexendo. Between March and May 2026, Crexendo filed a four-part disclosure sequence documenting its $35 million acquisition of Estech Systems — a deal that added 6,200+ retail accounts and roughly $26 million in annual revenue to the company's UCaaS platform.

Read More

About Market Tide Weekly

Market Tide Weekly is a filings‑first research publication built on one principle: the real story of the market lives in the paperwork — not the hype. We analyze the structures, incentives, ownership, and disclosures that shape how companies actually operate, move, and evolve.

Custom Research — The Market Tide Abyssal Deep Dive™

For readers, funds, founders, and operators who need deeper clarity, we offer custom, commissioned investigations through the Abyssal Deep Dive™ program. These are bespoke, high‑resolution analyses built from SEC filings, ownership maps, capital structure modeling, and narrative forensics — tailored to your specific company or sector.

If you need structural transparency, filings‑based insight, or a custom investigative report, the Abyssal Deep Dive™ delivers the deepest research we produce.

Our Weekly Publications

• Market Tide Weekly — Tuesday Edition A concise, filings‑driven briefing highlighting three micro‑cap or small‑cap tickers showing structural shifts, unusual volume, insider posture, or early accumulation. Calm analysis, no hype — just the signals that matter.

• Market Tide Deep Dive — Thursday Edition A long‑form investigative report focused on a single company. Each Deep Dive synthesizes filings, capital structure, governance, catalysts, and narrative positioning into a clear, accessible research artifact.